Re: you won’t see anyone buying this
in response to
by
posted on
Dec 07, 2023 06:08PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
fuzzy, would you be concerned about a stock dilution if you're offered $5 for your "ZHCLF" shares?
Koo